Ghana could be paying up to 30 times more than the recommended price for medicines, a new report says.
According to the report by the Center for Global Development (CEG), lower to middle-income countries such as Ghana, Ethiopia, Kenya and Nigeria, are losing out when purchasing what it calls branded generic drugs.